• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, December 21, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

‘Seeing the light’ behind radiation therapy

Bioengineer by Bioengineer
April 30, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

UBC research measures an accurate and precise dose of radiation

Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime. However, in a new study from UBC Okanagan and Duke University, researchers have developed a system they say may improve the ability to maximize radiation doses to cancer tissues while minimizing exposure to healthy ones.

“Radiation is a significant part of cancer therapy and it’s important to make it as effective as possible,” says Andrew Jirasek, a UBC Okanagan physics professor and senior author of the study. “The challenge is that radiation, while great at attacking rapidly dividing cancer cells, is also damaging to the surrounding healthy cells. Our solution is to make it easier to see exactly which tissues are getting a radiation dose and how much.”

The new system uses a specialized polymer gel used to assess both the 3D location and the dose of the treatment. The team’s first step was to validate the spatial accuracy of the gel, known as a dosimeter. They compared the dosimeter readings with traditional radiation treatment planning algorithms and found that the gel dosimeter was accurate in mapping the spatial location of the delivered radiation. Measurements of the radiation dose were also validated and visualized with the dosimeter.

The new system also allows for direct visualization of the radiation dose immediately after therapy, which results in highly efficient and accurate testing.

“Advances in delivery technology have enabled radiation beams to be rotated and adjusted to target the tumour and spare the healthy tissue, which reduces side effects,” he adds. “Now more advanced measuring devices are required to ensure that the dose and delivery of the treatment is accurate.”

Jirasek worked with colleagues from Duke University to take advantage of positioning systems already in place on most linear accelerators that deliver a radiation beam to the patient. The advantage of using the existing systems allowed for a new adjustment to be implemented without significant changes to the equipment.

“For the first time we are able to visualize a radiotherapy dose in true 3D and very quickly after the radiation has been delivered,” says Jirasek.

More than 50 percent of all cancer patients benefit from radiation therapy as it helps manage their disease. However, because radiation affects both healthy and tumor tissue, accurate and tightly controlled dosing is crucial. This new system may lead to improvements in dose accuracy, sensitivity and localization during therapy.

“The next steps are to improve the process so that it can move into the clinic–the sooner successful therapy is implemented, the better for the patient,” he adds.

###

Supported by a Natural Sciences and Engineering Research Council of Canada grant, this research was published in the International Journal of Radiation Oncology, Biology, and Physics.

April is Daffodil Month

For more than 60 years, Canadians have been acknowledging and supporting those affected by cancer by purchasing daffodils during the month of April. Donations to the Canadian Cancer Society have funded research, information and patient support services. Partially through these efforts, the cancer survival rate has increased from 35 to 60 per cent since 1950. In 2017, about 565 Canadians were diagnosed with cancer each day.

Media Contact
Christine Zeindler
[email protected]

Related Journal Article

https://news.ok.ubc.ca/2019/04/30/seeing-the-light-behind-radiation-therapy
http://dx.doi.org/10.1016/j.ijrobp.2018.12.023

Tags: cancerChemistry/Physics/Materials SciencesMolecular Physics
Share13Tweet8Share2ShareShareShare2

Related Posts

Antisense Therapy Reverses Developmental Defects in SMA Organoids

December 21, 2025

Unraveling Influenza A Host Tropism through Nucleotide Signatures

December 21, 2025

Frailty and Malnutrition Impact Pneumonia Severity in Vaccinated Elderly

December 21, 2025

Examining Flood Vulnerability and Evacuation Challenges

December 21, 2025
Please login to join discussion

POPULAR NEWS

  • Nurses’ Views on Online Learning: Effects on Performance

    Nurses’ Views on Online Learning: Effects on Performance

    70 shares
    Share 28 Tweet 18
  • NSF funds machine-learning research at UNO and UNL to study energy requirements of walking in older adults

    71 shares
    Share 28 Tweet 18
  • Unraveling Levofloxacin’s Impact on Brain Function

    53 shares
    Share 21 Tweet 13
  • Exploring Audiology Accessibility in Johannesburg, South Africa

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Antisense Therapy Reverses Developmental Defects in SMA Organoids

Black Soldier Fly Larvae Boost African Catfish Growth

Unraveling Influenza A Host Tropism through Nucleotide Signatures

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 70 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.